September 11, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
New Generic EpiPen Was Touted As A Lower Cost Option, But Its List Price Is The Same As One Already On MarketFDA Commissioner Scott Gottlieb said, “We cannot control commercial decisions on pricing, [but] importantly, we have found that having three or more generic competitors brings prices down more sharply than with only one or tw… Read More
Different Takes: Time To Reverse Rules Allowing Denial Of Birth Control; Make Reproductive Care A Priority For VeteransOpinion writers weigh in on women's heath care issues. from Kaiser Health News https://ift.tt/2FJe4fk … Read More
First Edition: November 28, 2018Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2FKKnKV … Read More
Viewpoints: If True, First Gene-Editing Of Babies Is Seriously Wrong On Many Fronts; Lessons On The Burden Of CaregivingEditorial pages focus on these health topics and others. from Kaiser Health News https://ift.tt/2r6gr1I … Read More
Chronically Ill, Traumatically Billed: The $123,000 Medicine For MS… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment